Get started
Author

Reena Lynam

OpenAlex ID: A5002197659
681 A phase 1 study of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, as monotherapy and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer
2022 · Christine Chung, Dimitrios Colevas, et al. · Regular and Young Investigator Award Abstracts · 3
PDF
438 A phase 1 trial of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, alone and in combination with pembrolizumab in patients with recurrent/metastatic HPV16+ head and neck cancer
2021 · Christine Chung, A Dimitrios Colevas, et al. · Regular and Young Investigator Award Abstracts · 2
PDF
636 A phase 1, open-label, dose escalation and expansion study of CUE-102 monotherapy in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers
2022 · Steven Margossian, John Powderly, et al. · Regular and Young Investigator Award Abstracts
PDF
Works count: 3
Citation count: 5
H-index: 2
I10-index:
Year
Topic
Type